BIO.News Newsletter

The 2025 BIO International Convention kicks off today in Boston—and the Bio.News team is on the ground, bringing you all the news and highlights. Here’s what we’re watching and how to follow. (966 words, 4 minutes, 49 seconds)

Measles vaccination and screening newborns for treatable diseases are preventive measures that can save lives and health care costs, as we explain in today’s edition. Also, officials share encouraging views during an FDA roundtable on CGT. (707 words, 3 minutes, 32 seconds)

As June begins, a lot of news: COVID-19 vaccine guidance continues to change, and BIO is dedicating its focus entirely to human health. (929 words, 4 minutes, 38 seconds)

We hope you had a restful Memorial Day weekend. Today, we recap last week’s big vaccine news, what RFK Jr. said on Capitol Hill, and the release of the MAHA report. (776 words, 3 minutes, 52 seconds)

A busy week on Capitol Hill brought promising developments on orphan drugs, PBM reform, tax deductions for R&D, and sustainable aviation fuels. (688 words, 3 minutes, 26 seconds)

We're back on a Tuesday with what BIO's saying about the Most Favored Nation Executive Order, and what to know about an important markup happening in the House today. (387 words, 1 minute, 57 seconds)

Today's jam-packed edition includes breaking news on a most-favored-nation drug policy and reconciliation legislation; also tariffs and an FDA-approved CRISPR pig. (843 words, 4 minutes, 12 seconds)

Today, we take a deep dive into what’s been happening in the state legislatures—here’s what BIO’s watching related to healthcare and agriculture. Plus, two bills designed to strengthen U.S. patents were introduced May 1. (790 words, 3 minutes, 57 seconds)

BIO launches a new campaign to explain why we vaccinate – and why it's good for America. We have details, plus how drug companies are investing in U.S. manufacturing, news on drug prices and IP, and more. (740 words, 3 minutes, 42 seconds)

A busy April is flying by. Today, we look at the executive order on drug pricing, the threat of pharmaceutical tariffs, a CDC meeting on immunization practices, and BIO’s appearances at many conferences across the U.S. (750 words, 3 minutes, 45 seconds)